Daniel J. Lippis
Equibles does not estimate personal net worth.
Get an email with a short summary when Edwards Lifesciences Corp publishes a filing, an earnings call transcript or a press release.
Get EW alertsAbout Daniel J. Lippis
Edwards Lifesciences Corp reported in an 8-K filed July 25, 2025 that Daniel J. Lippis was appointed Corporate Vice President responsible for Transcatheter Aortic Valve Replacement, effective September 1, 2025. Edwards Lifesciences Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Edwards Lifesciences Corp includes Bernard Zovighian (CEO and Board Member), Mr. Mussallem (CEO), Mr. Zovighian (CEO) and 7 others.
“In connection with Mr. Wood's departure, effective September 1, 2025, Daniel J. Lippis, the Company's current Corporate Vice President, Japan, Greater China and Asia Pacific, will serve as the Company's Corporate Vice President responsible for Transcatheter Aortic Valve Replacement.”
Affiliation history
-
Edwards Lifesciences Corp (EW)
SEC 8-K
Current2025-09-01–present
Company network
Leadership on record at Edwards Lifesciences Corp
- Bernard Zovighian CEO, Board Member
- Mr. Mussallem CEO
- Mr. Zovighian CEO
- Mr. Ullem CFO
- Scott Ullem CFO
- Theodora Mistras CFO
- Andrew M. Dahl Chief Accounting Officer
- Bernard J. Zovighian Board Member
- David T. Feinberg, M.D. Board Member
- David T. Feinberg, MD Board Member